Study guide

Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

Key Takeaways Explain This Topic AI

Morning recurrence suggests epithelial attachment failure, whereas reduced sensation suggests neurotrophic disease.

Persistent defects require assessment for exposure, toxicity, infection and stromal thinning.

EU cenegermin treatment has an adult moderate/severe indication and a specific eight-week regimen.

Vitamin A deficiency requires systemic cause assessment and age-appropriate replacement, with urgent care for keratomalacia.

Last updated: October 2026

Three different routes to epithelial failure

Corneal epithelium can fail because it does not attach securely, because its sensory and trophic support is impaired, or because a systemic nutritional problem alters the surface. A persistent defect therefore requires more than another antibiotic bottle. Determine onset, pain, recurrence, sensation, exposure, lid closure, tear function and stromal integrity. An epithelial defect can become infected irrespective of its original mechanism, and significant thinning changes urgency.

Recurrent corneal erosion

Recurrent corneal erosion (RCE) produces repeated epithelial breakdown, often with pain on waking. Prior abrasion and epithelial basement membrane dystrophy are important associations. Abnormal attachment and nocturnal lid adherence can lead to epithelial avulsion when the eye opens. Between attacks the cornea may appear nearly normal or show map-dot-fingerprint changes. Examine both eyes and record whether the current problem is an active defect, residual irregularity or recurrent pain without a visible break.

During an episode, assess for infection and provide lubrication, pain relief and suitable epithelial protection. A bandage contact lens can help in selected cases but carries infection risk and needs follow-up. Long-term lubrication or hypertonic preparations may reduce recurrence in appropriate eyes; lid disease and tear dysfunction should also be addressed. Do not provide repeated take-home topical anaesthetic as routine therapy: misuse can produce severe epithelial and stromal damage.

Persistent recurrence can lead to epithelial debridement with diamond-burr polishing, phototherapeutic keratectomy (PTK) or selected anterior stromal puncture. Choose by lesion location, optical importance, thickness and previous treatment. Stromal puncture can create visible scars and is usually avoided in the central visual axis. The randomised diamond-burr study supports this approach in a defined RCE population, but does not make it mandatory for every first episode. Discuss haze, refractive change and the possibility of further recurrence with laser treatment.

Neurotrophic keratopathy

Neurotrophic keratopathy follows reduced trigeminal sensory/trophic support. Causes include herpes infection, diabetes, surgery, trauma and proximal nerve disease. A relatively painless persistent defect in an eye with reduced sensation should raise suspicion; absence of pain does not imply low risk. Test sensation before anaesthetic and assess blink, tear function and exposure. A defect may progress to stromal ulceration, melt or perforation.

A commonly used staging approach separates epithelial irregularity, persistent epithelial defect and stromal ulceration/thinning. It helps describe severity but does not replace measurement of the actual defect and depth. Remove avoidable toxic medications and treat exposure or lid problems. Preservative-free lubrication, serum-derived preparations, amniotic membrane, a suitable protective lens or tarsorrhaphy may support healing, depending on the eye. Exclude and treat infection and reassess the underlying nerve cause.

Cenegermin is recombinant human nerve growth factor. In the EU, Oxervate is authorised for adults with moderate or severe neurotrophic keratitis, with one drop every two hours six times daily for eight weeks. It is a specialist-supervised treatment, not a general dry-eye prescription. Storage, vial preparation and timing must follow the current product information. The EMA Oxervate information identifies the indication and regimen; it does not guarantee recovery of every scarred or thinned cornea.

Vitamin A deficiency and xerophthalmia

Vitamin A is required for normal epithelial differentiation and the visual cycle. Deficiency can produce night blindness, conjunctival xerosis, Bitot spots, corneal xerosis and, in severe disease, keratomalacia. Consider malnutrition, malabsorption, restrictive diets, bariatric or intestinal disease and liver-related contexts. A child can have systemic malnutrition requiring urgent care as well as ocular disease. Night blindness alone has other causes, including inherited retinal disorders.

Keratomalacia can destroy tissue rapidly and may be associated with poor sensation or limited symptoms. Arrange urgent systemic assessment and vitamin replacement under an appropriate age- and pregnancy-specific regimen, together with ocular protection and infection assessment. Do not improvise high-dose vitamin A during pregnancy or assume that ordinary lubricants correct the nutritional mechanism. Treat the reason for deficiency to prevent recurrence.

Presentation Most useful discriminator Main treatment objective

Recurrent painful episode on waking Attachment disorder and prior abrasion/EBMD Heal the defect and improve durable attachment

Persistent relatively painless defect Reduced sensation or exposure Restore protection and trophic support; prevent melt

Night blindness with xerosis/systemic risk Nutritional or malabsorption history Correct systemic deficiency and protect the surface

Choosing the next step

An adult with previous HSV and a painless defect needs sensation testing and neurotrophic management even if there is no active dendrite. A patient with repeated morning pain and normal sensation may need an attachment-focused approach. A malnourished child with xerosis requires urgent systemic treatment. For every pattern, document acuity, size, stromal depth and infection findings, and arrange a review interval that reflects the risk of deterioration. Healing the epithelium is the immediate goal; durable prevention requires correcting its specific failure mechanism.

Sections you finish are checked off in the contents.

  • Up Next
  • Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy
  • Chapter 16: Surface Reconstruction and Keratoplasty